Consistency of the efficacy of cetirizine and ebastine on skin reactivity

被引:33
作者
Frossard, N
Melac, M
Benabdesselam, O
Pauli, G
机构
[1] Fac Pharm, Illkirch, France
[2] Hop Univ, Serv Pneumol, INSERM, U425, Strasbourg, France
[3] UCB Pharma, Nanterre, France
关键词
D O I
10.1016/S1081-1206(10)62941-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: At therapeutic dosage, cetirizine and ebastine induce significant inhibition of skin reactivity to histamine. The consistency of their efficacy, that is, efficacy with the least interindividual variability among subjects, has not been carefully assessed, however. Objective: To compare the consistency and efficacy of these antihistamines on skin reactivity. Methods: Twenty-four healthy volunteers participated in a randomized double-blind crossover study. The areas of wheals and flares induced by increasing (0, 5, 10, 50, 100, 200, and 300 mg/mL) histamine concentrations, administered by prick tests, were measured before and four hours after intake of 10 mg of each antihistamine, allowing concentration-response curves to be established. The threshold histamine concentrations inducing wheal areas of 3 mm2 (positivity) were calculated by interpolation. The coefficient of variation (SD/mean %) was used to evaluate the consistency of the response. Results: Pretreatment concentration-response curves were similar, and threshold concentrations identical (0.29 mg/mL and 0.34 mg/mL for cetirizine and ebastine, respectively). For both, curves were lower after treatment than before. After cetirizine, the threshold concentration was significantly higher (217 mg/mL) than after ebastine (0.82 mg/mL) (P < .001), and total inhibition of the wheal reaction was observed in 21 of 24 patients at the lowest histamine concentration and in 17 of 24 at the highest. Ebastine never totally inhibited reaction, even to 5 mg/mL of histamine. Over the entire concentration-response curve, the coefficient of variation for the wheal reaction was 6.3% for cetirizine and 72.6% for ebastine, and, for flares, 11.0% and 83.7%, respectively. Hence, variability was much lower after cetirizine. Conclusion: Our study shows clearly that the efficacy of a single therapeutic dosage of cetirizine is consistently good for suppression of cutaneous reactivity to histamine in healthy volunteers. The need for ebastine to metabolize into the active carebastine might explain its lesser consistency.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 25 条
[1]  
BERNHEIM J, 1991, AGENT ACTION SUPPL, V34, P269
[2]   CETIRIZINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN ALLERGIC RHINITIS, POLLEN-INDUCED ASTHMA, AND CHRONIC URTICARIA [J].
CAMPOLIRICHARDS, DM ;
BUCKLEY, MMT ;
FITTON, A .
DRUGS, 1990, 40 (05) :762-781
[3]  
CHARLESWORTH EN, 1992, J PHARMACOL EXP THER, V262, P964
[4]   INHIBITORY EFFECTS OF ORALLY OR SUBLINGUALLY ADMINISTERED CETIRIZINE ON HISTAMINE-INDUCED WEALS AND FLARES AND THEIR CORRELATION WITH CETIRIZINE PLASMA-CONCENTRATIONS [J].
COULIE, PJ ;
GHYS, L ;
RIHOUX, JP .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1991, 19 (02) :174-179
[5]   ASSESSMENT OF THE WHEAL SIZE AND SKIN BLOOD-FLOW OF THE ERYTHEMA INDUCED BY HISTAMINE AND ITS MODIFICATION WITH CETIRIZINE AND EBASTINE - A CROSSOVER, DOUBLE-BLIND-STUDY [J].
DELACUADRA, J ;
TERUEL, M ;
TEIXIDO, P ;
ROMA, J .
DERMATOLOGY, 1994, 188 (02) :131-134
[6]   Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults [J].
Gehanno, P ;
BremardOury, C ;
Zeisser, P .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1996, 76 (06) :507-512
[8]  
Guerra L, 1994, J EUR ACAD DERMATOL, V3, P148
[9]  
HANNUKSELA M, 1993, ANN ALLERGY, V70, P127
[10]   TREATMENT OF CHRONIC URTICARIA WITH CETIRIZINE DIHYDROCHLORIDE A NON-SEDATING ANTIHISTAMINE [J].
JUHLIN, L ;
ARENDT, C .
BRITISH JOURNAL OF DERMATOLOGY, 1988, 119 (01) :67-72